K Number
K221466
Device Name
IPL Hair Removal Device, model: AI01, AI06, AI08, AI16, AI17
Date Cleared
2022-08-12

(85 days)

Product Code
Regulation Number
878.4810
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The IPL Hair Removal Device (Model : AI01, AI06, AI08, AI16, AI17) is intended for the removal of unwanted body hair.
Device Description
IPL Hair Removal Device, models: Al01, Al06, Al08, Al16, Al17 are hand-held overthe-counter devices for the permanent reduction of hair growth based on Intense Pulsed Light (IPL). The device is powered by an external power adapter and its IPL emission activation is by finger switch. The device contains a Xenon arc flashlamp, a skin sensor to detect appropriate skin contact, and a skin color detection system to detect the skin color. If the device is not properly applied to the treatment area (in full contact with the skin), the device cannot emit the treatment light pulses. The skin color detection system detects whether a skin tone is suitable for treatment. If the skin tone is not in the range suitable for treatment, the device is designed to not emit the treatment light pulses. The light pulses are selectively absorbed by the hair follicles, which results in the hair follicles being temporarily heated. This results in a reduction of hair growth from the treated hair follicles.
More Information

Not Found

No
The description details a device with sensors and safety mechanisms based on direct measurements (skin contact, skin color detection) and standard IPL technology. There is no mention of learning, adaptation, or complex pattern recognition typically associated with AI/ML. The "AI" in the model numbers appears to be a product identifier, not an indication of AI technology.

No
A therapeutic device is used to treat or cure a disease or condition. This device is intended for hair removal, which is a cosmetic procedure, not a therapeutic one.

No

The device is an IPL hair removal device, intended for the removal of unwanted body hair by selectively heating hair follicles to reduce hair growth. It does not diagnose any medical conditions or diseases.

No

The device description clearly outlines hardware components such as a hand-held device, external power adapter, Xenon arc flashlamp, skin sensor, and skin color detection system. It is not solely software.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. These tests are performed outside of the body (in vitro).
  • Device Function: The IPL Hair Removal Device works by applying Intense Pulsed Light directly to the skin to target hair follicles. It does not analyze samples taken from the body.
  • Intended Use: The intended use is for the removal of unwanted body hair, which is a cosmetic or aesthetic procedure, not a diagnostic test.

The device description clearly outlines its function as a light-based treatment applied externally to the body. The inclusion of features like a skin sensor and skin color detection system are safety mechanisms for the application of the light, not diagnostic tools.

N/A

Intended Use / Indications for Use

The IPL Hair Removal Device (Model : AI01, AI06, AI16, AI17) is intended for the removal of unwanted body hair.

Product codes

OHT

Device Description

IPL Hair Removal Device, models: Al01, Al06, Al08, Al16, Al17 are hand-held overthe-counter devices for the permanent reduction of hair growth based on Intense Pulsed Light (IPL). The device is powered by an external power adapter and its IPL emission activation is by finger switch. The device contains a Xenon arc flashlamp, a skin sensor to detect appropriate skin contact, and a skin color detection system to detect the skin color. If the device is not properly applied to the treatment area (in full contact with the skin), the device cannot emit the treatment light pulses. The skin color detection system detects whether a skin tone is suitable for treatment. If the skin tone is not in the range suitable for treatment, the device is designed to not emit the treatment light pulses. The light pulses are selectively absorbed by the hair follicles, which results in the hair follicles being temporarily heated. This results in a reduction of hair growth from the treated hair follicles.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Body

Indicated Patient Age Range

Adult

Intended User / Care Setting

Over-The-Counter Use

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Non-clinical testing listed in the table below was performed to demonstrate that the device can be used safely and effectively for the proposed indications for use.

StandardsStandards NameResults
ANSI AAMI ES60601-1:2005/(R)2012 and A1:2012Medical Electrical Equipment - Part 1: General Requirements For Basic Safety And Essential PerformancePass
IEC 60601-1-2: 2014Medical Electrical Equipment -- Part 1-2: General Requirements For Basic Safety And Essential Performance -- Collateral Standard: Electromagnetic Disturbances -- Requirements And TestsPass
IEC 60601-1-11: 2015Medical Electrical Equipment - Part 1-2: General Requirements For Basic Safety And Essential Performance - Collateral Standard: Electromagnetic Disturbances - Requirements And TestsPass
ISO 60601-2-57: 2011Particular requirements for the basic safety and essential performance of non-laser light source equipment intended for therapeutic, diagnostic, monitoring and cosmetic/aesthetic usePass
IEC 62471: 2006Photobiological safety of lamps and lamp systemsPass
ISO 10993-5:2009Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicityPass
ISO 10993-10:2010Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitizationPass
IEC 62304:2006+A1:2015Medical device software - Software life cycle processesPass

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K212897

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.

0

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

August 12, 2022

Shenzhen Century Dongyuan Technology Co Ltd. % You Yijie Manager Qimmiq Medical Consulting Service Co., Ltd. RM.406, Building C. Run Science Park, No.18 Shenzhou Road, Huangpu Guangzhou, Guangdong 510663 China

Re: K221466

Trade/Device Name: IPL Hair Removal Device, model: AI01, AI06, AI08, AI16, AI17 Regulation Number: 21 CFR 878.4810 Regulation Name: Laser Surgical Instrument For Use In General And Plastic Surgery And In Dermatology Regulatory Class: Class II Product Code: OHT Dated: May 19, 2022 Received: May 19, 2022

Dear You Yijie:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

1

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Jianting Wang Acting Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known)

K221466

Device Name

IPL Hair Removal Device, model: AI01, AI06, AI08, AI16, AI17

Indications for Use (Describe)

The IPL Hair Removal Device (Model : AI01, AI06, AI16, AI17) is intended for the removal of unwanted body hair.

Type of Use (Select one or both, as applicable)

| Prescription Use (Part 21 CFR 801 Subpart D)

X Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.qov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Section 5: 510(K) Summary

1. Submitter's Information

Establishment Registration Information:
Name:Shenzhen Century Dongyuan Technology Co Ltd.
Address:Floor 2, Building B1, Gonghe Fourth Industrial Zone,
Shajing Street, Bao'an District, Shenzhen City,
Guangdong Province China
Contact Person of applicant:
Name:He Wang
Address:Floor 2, Building B1, Gonghe Fourth Industrial
Zone, Shajing Street, Bao'an District, Shenzhen
City, Guangdong Province China
TEL:+86 13798450554
Email:aijofi01@163.com
Contact Person of the Submission:
Name:You Yijie
Address:RM.406, Building C, Run Science Park, No.18
Shenzhou Road, Huangpu, Guangzhou,
Guangdong 510663 P.R.China
TEL:(+86)020-82245821
FAX:(+86)020-82245821
Email:jet.you@qimmiq-med.com

Date prepared: May 13, 2022

2. Device Information

Trade Name:IPL Hair Removal Device, model: AI01, AI06, AI08, AI16, AI17
Classification name:Light Based Over-The-Counter Hair Removal
Common or Usual Name:Powered Light Based Non-Laser Surgical Instrument With
Thermal Effect
Review panel:General & Plastic Surgery
Product code:OHT
Regulation Class:II
Regulation Number:878.4810

3. Predicate Device Information

4

| 510(k) submitter/holder: | Shenzhen Century Dongyuan Technology Co
Ltd. |
|--------------------------|--------------------------------------------------------------------------|
| 510(K) Number: | K212897 |
| Trade Name: | IPL Hair Removal Device |
| Model: | AI01 |
| Classification name: | Powered Light Based Non-Laser Surgical
Instrument With Thermal Effect |
| Review panel: | General & Plastic Surgery |
| Product code: | ONF |
| Regulation Class: | II |
| Regulation Number: | 878.4810 |

4. Device description

IPL Hair Removal Device, models: Al01, Al06, Al08, Al16, Al17 are hand-held overthe-counter devices for the permanent reduction of hair growth based on Intense Pulsed Light (IPL). The device is powered by an external power adapter and its IPL emission activation is by finger switch. The device contains a Xenon arc flashlamp, a skin sensor to detect appropriate skin contact, and a skin color detection system to detect the skin color. If the device is not properly applied to the treatment area (in full contact with the skin), the device cannot emit the treatment light pulses. The skin color detection system detects whether a skin tone is suitable for treatment. If the skin tone is not in the range suitable for treatment, the device is designed to not emit the treatment light pulses. The light pulses are selectively absorbed by the hair follicles, which results in the hair follicles being temporarily heated. This results in a reduction of hair growth from the treated hair follicles.

5. Indications for Use

The IPL Hair Removal Device (Model: AI01, AI06, AI08, AI16, AI17) is intended for the removal of unwanted body hair.

6. Summary of technological characteristics of device

| SE
Comparisons | Subject device
(IPL Hair Removal Device,
model: Al01, Al06, Al08, Al16, Al17) | Predicate device
(IPL Hair Removal Device,
model: Al01) | Discussion of
difference |
|-------------------|-------------------------------------------------------------------------------------|---------------------------------------------------------------|---------------------------------------------------------------------------------|
| 510K Number | / | K212897 | / |
| Classification | 21CFR 878.4810 | 21CFR 878.4810 | Same |
| Product Code | OHT | ONF | Technical
Method
equivalent, have
same
Classification
regulation |

compared to the predicate devices (K212897)

5

FDA ClassIIIISame
ModelAI01, AI06, AI08, AI16, AI17AI01/
Indications for UseThe IPL Hair Removal Device (Model:
AI01, AI06, AI08, Al16, Al17) is intended
for the removal of unwanted body hair.The IPL Hair Removal Device
(Model: Al01) is intended for the Same
Type of useOver-The-Counter UsePrescription UseDifferent
DesignHand-heldHand-heldSame
Patient PopulationAdultAdultSame
TechnologyIntense Pulse Light (IPL)Intense Pulse Light (IPL)Same
Dimensions1402035614020356Same
Power sourcean external power supplyan external power supplySame
Light sourceXenon Arc FlashlampXenon Arc FlashlampSame
Wavelength510nm~1100nm510nm~1100nmSame
Spot Size3.1 cm²3.1 cm²Same
Max. Fluence
(J/cm²)3.8-5.2 J/cm²3.8-5.2 J/cm²Same
Pulse duration3 milliseconds3 millisecondsSame
Output energy12-16 J12-16 JSame
Pulsing
ControlFinger switchFinger switchSame
Skin contact sensorYesYesSame
Skin Tone detectionYesNoDifferent
Software
ControlYesYesSame
Electrical
safety, EMC,
Biological
EvaluationIEC 60601-1
IEC 60601-1-2
IEC 60601-1-11
IEC 60601-2-57
IEC 62471
ISO 10993-5
ISO 10993-10IEC 60601-1
IEC 60601-1-2
IEC 60601-1-11
IEC 60601-2-57
IEC 62471
ISO 10993-5
ISO 10993-10Same

7. Discussion of Non-Clinical Tests Performed for Safety and

effectiveness are as follows

The modifications to the device have been designed and assessed under design control processes compliant with FDA 21 CFR 820. A risk analysis was conducted to assess the impact of the changes on the subject device using internal design control procedures and a fault tree analysis described in the FDA-recognized version of ISO 14971.

These risks were mitigated using planned measures that included testing to recognized FDA consensus standards. Changes in software were verified and validated using the software development process.

Non-clinical testing listed in the table below was performed to demonstrate that the device can be used safely and effectively for the proposed indications for use.

6

StandardsStandards NameResults
ANSI AAMI ES60601-
1:2005/(R)2012 and
A1:2012Medical Electrical Equipment - Part 1:
General Requirements For Basic Safety
And Essential PerformancePass
IEC 60601-1-2: 2014Medical Electrical Equipment -- Part 1-
2: General Requirements For Basic
Safety And Essential Performance --
Collateral Standard: Electromagnetic
Disturbances -- Requirements And
TestsPass
IEC 60601-1-11: 2015Medical Electrical Equipment - Part 1-2:
General Requirements For Basic Safety
And Essential Performance - Collateral
Standard: Electromagnetic
Disturbances - Requirements And
TestsPass
ISO 60601-2-57: 2011Particular requirements for the basic
safety and essential performance of
non-laser light source equipment
intended for therapeutic, diagnostic,
monitoring and cosmetic/aesthetic usePass
IEC 62471: 2006Photobiological safety of lamps and
lamp systemsPass
ISO 10993-5:2009Biological evaluation of medical devices
  • Part 5: Tests for in vitro cytotoxicity | Pass |
    | ISO 10993-10:2010 | Biological evaluation of medical devices
  • Part 10: Tests for irritation and skin
    sensitization | Pass |
    | IEC
    62304:2006+A1:2015 | Medical device software - Software life
    cycle processes | Pass |

8. Discussion of Clinical Accuracy Testing Performed

There was no clinical testing performed.

9. Conclusions

The subject device IPL Hair Removal Device models Al01, Al06, Al08, Al16, and Al17, in this 510(k) use the same IPL technology that is used in the predicate device K212897. Differences between the subject device models and predicate device do not raise new types of questions regarding safety and effectiveness, and performance testing demonstrates that the proposed device can be used safely and effectively for the proposed indications for use. The proposed IPL Hair Removal Device is considered to be substantially equivalent to the predicate K212897 device.